Applied Health Economics And Health Policy
Points Position
CEF.UP+NIPE (average of all rankings) (2012) 5.63 465/501
Australian RC (2010) 25.0 451/479
CNRS (2008) 20.0 314/336
Ideas discounted recursive impact factor (2012) 0.2 344/396
Source Normalized Impact per Paper (SNIP) (2011) 5.69 375/476
Impact Factor (2019) 2.44 112/440
SJR - Scimago (2019) 0.92 220/549
Count (2021) 1.0 158/651
Articles 5:

Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment
James Lomas, Jessica Ochalek, Rita Faria
vol. 20, 2022, p. 13-18.

Inference Procedures to Quantify the Efficiency-Equality Trade-Off in Health from Stated Preferences: A Case Study in Portugal
Micaela Pinho, Anabela Botelho
vol. 16, 2018, p. 503-513.

Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients Who Are Unsuitable for Full-Dose Fludarabine-Based Therapy
Ana Teresa Paquete, Luis Silva Miguel, Ursula Becker, Catarina Pereira, Carlos Gouveia Pinto
vol. 15, 2017, p. 501-512.

Cost-Effectiveness Analysis of 3-D Computerized Tomography Colonography versus Optical Colonoscopy for Imaging Symptomatic Gastroenterology Patients
Manuel Gomes, Robert W. Aldridge, Peter Wylie, James Bell, Owen Epstein
vol. 11, 2013, p. 107-117.

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
Elamin H. Elbasha, Jagpreet Chhatwal, Shannon A. Ferrante, Antoine C. El Khoury, Pedro A. Laires
vol. 11, 2013, p. 65-78.